<DOC>
	<DOCNO>NCT01400477</DOCNO>
	<brief_summary>The investigator hypothesize sustained-release DMXB-A-SR ( 3-2,4 dimethoxybenzylidene anabaseine sustain release ) provide clinical improvement cognition patient schizophrenia smoker non-smokers . The study drug may also maintain abstinence cigarette smoke improve symptom patient schizophrenia .</brief_summary>
	<brief_title>Nicotinic Receptors Schizophrenia</brief_title>
	<detailed_description>Patients schizophrenia screen enrol one week placebo trial addition exist antipsychotic medication . If pill compliance great 80 % , receive baseline clinical , cognitive , brain image clinical laboratory examination physical examination , vital sign , cardiogram . Then receive randomize double blind trial either DMXB-A-SR ( 3-2,4 dimethoxybenzylidene anabaseine sustain release ) placebo comparator addition exist antipsychotic medication . After one month receive repeat clinical , cognitive , brain image test clinical laboratory examination physical examination , vital sign , cardiogram .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>3- ( 2,4-dimethoxybenzylidene ) anabaseine</mesh_term>
	<criteria>Subjects select 18 65 year old good general health . We include people fulfill Diagnostic Statistical Manual IVText Revision ( DSMIVTR ) criteria schizophrenia schizoaffective disorder . Smokers smoke least 20 cigarette per day . Nonsmokers also enrol . Subjects normal vital sign , hematology , serum chemistry , EKG , urinalysis negative drug screen entry study . Subjects fluent English . Smoking subject interested stop smoke near future interested nicotine replacement therapy . Subjects histories neurological illness , liver disease , severe hypertension ( cutoff blood pressure 160/100 ) cardiac disease , renal failure ( cutoff creatinine 1.4 ) exclude . Subjects currently meet DSMIVTR criterion substance dependence nicotine , cannabis , alcohol exclude . Women capable pregnancy acceptable form birth control exclude . Subjects treat Clozapine exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Drug Trial</keyword>
	<keyword>Smoking</keyword>
	<keyword>Smoking Cessation</keyword>
	<keyword>Cognition</keyword>
	<keyword>Mental Focus</keyword>
</DOC>